
## ‡∏≠‡∏≤‡∏à‡∏°‡∏µ‡∏™‡∏£‡∏∏‡∏õ‡∏ú‡∏¥‡∏î‡πÑ‡∏î‡πâ‡∏ô‡∏∞‡∏Ñ‡πâ‡∏≤‡∏ö ‡∏≠‡πà‡∏≤‡∏ô‡∏Å‡∏±‡∏ô‡∏≠‡∏¢‡∏≤‡∏Å‡∏£‡∏∞‡∏°‡∏±‡∏î‡∏£‡∏∞‡∏ß‡∏±‡∏á‡∏ô‡πâ‡∏≤ ‡πÄ‡∏ß‡πá‡∏ö‡∏ô‡∏µ‡πâ‡πÄ‡∏Å‡∏¥‡∏î‡∏à‡∏≤‡∏Å‡∏Ñ‡∏ß‡∏≤‡∏°‡∏≠‡∏¢‡∏≤‡∏Å‡∏´‡∏≤‡∏ó‡∏≥‡∏Ç‡∏≠‡∏á‡∏ï‡∏±‡∏ß‡πÄ‡∏≠‡∏á‡∏à‡πâ‡∏≤‡∏≤‡∏≤ #‡∏û‡∏≠‡∏à‡∏≠ üíñ

**‡πÄ‡∏ß‡πá‡∏ö‡πÑ‡∏ã‡∏ï‡πå‡∏ô‡∏µ‡πâ‡∏£‡∏±‡∏ô‡πÑ‡∏î‡πâ‡πÇ‡∏î‡∏¢**
- [Quartz ‡∏Ç‡∏≠‡∏á Jacky Zhao](https://github.com/akumaharit/quartz)
- [Github Page ‡∏Ç‡∏≠‡∏á Github](https://pages.github.com/)
- [Obsidian (Markdown Editor)](https://obsidian.md/)
- [Hugo (website framework)](https://gohugo.io/)

**Changelogs**
- 8/3/2566: published website, PTHER I data from personal obsidian vault, excluding some notes causing website deployment errors.

**Todo**
- ‡∏à‡∏±‡∏î‡πÄ‡∏£‡∏µ‡∏¢‡∏á‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡πÉ‡∏´‡∏°‡πà‡πÅ‡∏•‡πâ‡∏ß push ‡πÄ‡∏Ç‡πâ‡∏≤‡∏≠‡∏µ‡∏Å‡∏Ñ‡∏£‡∏±‡πâ‡∏á
- ‡∏´‡∏≤‡∏ó‡∏≤‡∏á sync ‡∏ó‡∏µ‡πà‡∏î‡∏µ‡∏Å‡∏ß‡πà‡∏≤‡∏ô‡∏µ‡πâ‡∏£‡∏∞‡∏´‡∏ß‡πà‡∏≤‡∏á personal vault ‡∏Å‡∏±‡∏ö‡πÄ‡∏ß‡πá‡∏ö
- ‡∏®‡∏∂‡∏Å‡∏©‡∏≤ hugo
- ‡∏®‡∏∂‡∏Å‡∏©‡∏≤ github action
- ‡∏≠‡∏≤‡∏à‡∏ô‡∏≥‡∏°‡∏≤‡∏õ‡∏£‡∏∞‡∏¢‡∏∏‡∏Å‡∏ï‡πå‡πÉ‡∏ä‡πâ‡∏Å‡∏±‡∏ö‡∏ï‡∏¥‡∏ß‡πÉ‡∏ö‡∏õ‡∏£‡∏∞‡∏Å‡∏≠‡∏ö? ‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏°‡∏µ vault ‡πÉ‡∏ö‡∏õ‡∏£‡∏∞‡∏Å‡∏≠‡∏ö‡∏≠‡∏¢‡∏π‡πà‡πÅ‡∏•‡πâ‡∏ß
- ‡∏õ‡∏¥‡∏î‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡πà‡∏ß‡∏ô‡∏ï‡∏±‡∏ß?

### Exam 1

| Topic                                                                            | Percent |
| -------------------------------------------------------------------------------- | ------- |
| [[notes/1 - Asthma 2022]] / [[notes/2 - COPD 2022]] / [[notes/3 - Drug Induced Pulmonary Disease]]             | 7.7%    | 
| [[notes/4 - Respiratory Failure]]                                                          | 7.7%    |
| [[notes/5 - Acute Asthma & COPD Exacerbation]]                                             | 7.7%    |
| [[6 - ADR Cross Reactivity]]                                                         | 0%      |
| [[notes/7 - Glaucoma (‡∏ï‡πâ‡∏≠‡∏´‡∏¥‡∏ô)]] / [[notes/8 - AMD]]                                                           | 7.7%    |
| [[notes/9 - Drug Induced Eye Disorder]] / [[notes/10 - Drug Induced Ear Disorder]]                                               | 7.7%    |

[[notes/Exam 1 Addition Notes]]


---

### Exam 2

| Topic                                    | Percent |
| ---------------------------------------- | ------- |
| [[notes/11 - UGIB]]                            | ‡∏Ñ‡∏≤‡∏ö 8   |
| [[notes/12 - IBD]]                             | ‡∏Ñ‡∏≤‡∏ö 8   |
| [[notes/13 - Viral Hepatitis]]                 | ‡∏Ñ‡∏≤‡∏ö 9   |
| [[notes/14 - Alcoholic hepatitis]]             | ‡∏Ñ‡∏≤‡∏ö 9   |
| [[notes/15 - Cirrhosis]]                       | ‡∏Ñ‡∏≤‡∏ö 10  |
| [[notes/16 - DIGI]]                            | ‡∏Ñ‡∏≤‡∏ö 11  |
| [[notes/17 - DILI]]                            | ‡∏Ñ‡∏≤‡∏ö 11  |
| [[notes/18 - Drug dosing in liver impairment]] | ‡∏Ñ‡∏≤‡∏ö 11  |
| [[notes/20 - Synovial Analysis]]               | ‡∏Ñ‡∏≤‡∏ö 12  |
| [[notes/21 - OA]]                              | ‡∏Ñ‡∏≤‡∏ö 12  |
| [[notes/22 - RA]]                              | ‡∏Ñ‡∏≤‡∏ö 13  |
| [[notes/23 - Drug Induced bone joint & muscle disease]]                                         |  ‡∏Ñ‡∏≤‡∏ö 13       |
| [[24 - Steroid]]                         | ‡∏Ñ‡∏≤‡∏ö 14  |
| [[notes/25 - SLE]]                             | ‡∏Ñ‡∏≤‡∏ö 14  |

- ‡πÇ‡∏£‡∏Ñ‡∏Ç‡πâ‡∏≠‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î ‡∏ú‡∏π‡πâ‡∏´‡∏ç‡∏¥‡∏á‡∏û‡∏ö‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤‡∏ú‡∏π‡πâ‡∏ä‡∏≤‡∏¢ ‡∏¢‡∏Å‡πÄ‡∏ß‡πâ‡∏ô gout
- ‡πÄ‡∏î‡∏µ‡πã‡∏¢‡∏ß‡∏≠‡πà‡∏≤‡∏ô‡∏ä‡∏µ‡∏ó‡∏û‡∏µ‡πà‡∏¢‡∏® 3 ‡∏≠‡∏±‡∏ô‡∏ô‡∏±‡πâ‡∏ô DIGI DILI dose in liver impair ‡πÅ‡∏•‡∏∞ drug induced ‡∏Ç‡∏≠‡∏á‡∏û‡∏µ‡πà‡∏ô‡∏∏‡∏™ ‡∏≠‡πà‡∏≤‡∏ô‡∏à‡∏ö‡∏ó‡∏µ‡∏•‡∏∞‡∏≠‡∏±‡∏ô ‡πÅ‡∏•‡πâ‡∏ß‡∏≠‡πà‡∏≤‡∏ô‡πÇ‡∏û‡∏¢ ‡πÅ‡∏•‡πâ‡∏ß‡∏ó‡∏≥‡∏™‡∏£‡∏∏‡∏õ ‡∏ó‡∏≥‡∏ã‡πâ‡∏≥‡∏à‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏à‡∏ö